EU Risks Global Vaccine Battle With Bold Export Control Plan
- European Commission defends plan to demand prior authorization
- Businesses say move could spark retaliation by others
This article is for subscribers only.
The European Union risks sparking a global vaccine battle after unveiling a drastic plan to restrict exports of Covid-19 shots.
The move affects drug companies such as Pfizer Inc. and AstraZeneca Plc, with the EU accused by an international trade group and the World Health Organization of engaging in damaging protectionism. The U.K. government, fresh from negotiating its exit from the bloc, called on the EU to refrain from disrupting Britain’s vaccine supply and demanded an explanation.